SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on January 4, 2011. The report discloses the issuance of a press release regarding consolidated financial results for the second quarter of fiscal year 2011, ended November 28, 2010. Note: The request metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as "LANDEC CORPORATION".
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not reproduced in the provided text.
Material Changes
The filing does not contain specific data regarding material changes versus the prior comparable period. It serves solely as a notification that the second-quarter results have been announced.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, or contingencies. It states that the information in the report and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor subject to the liabilities of that Section.
Investor Verification Checklist
- Verify the correct registrant name (Landec Corporation vs. Lifecore Biomedical, Inc.) to ensure the correct entity is being analyzed.
- Retrieve and review Exhibit 99.1 (Press Release dated January 4, 2011) for actual financial figures, as they are absent from the 8-K body text.
- Confirm the fiscal quarter end date of November 28, 2010, for accurate period comparison.
- Note the legal disclaimer that the press release information is not deemed "filed" under Section 18 of the Exchange Act.